These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2906298)

  • 1. Byciclic compounds with potential antiulcer and/or antisecretory activity. III--2-substituted tetrahydrothiazolo-[5,4-c]pyridines.
    Scarponi U; Lazzarini AM; Caprioli R; de Castiglione R; Toti D; Vaghi F; Castello R; Ceserani R
    Farmaco Sci; 1988; 43(7-8):575-96. PubMed ID: 2906298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bicyclic compounds with potential antiulcer and/or antisecretory activity. I. 4,5,6,7-Tetrahydrobenzimidazoles.
    Scarponi U; Cimaschi R; Rusconi L; Santangelo F; Arcari G; Castello R; Toti D; de Castiglione R
    Farmaco Sci; 1985 Nov; 40(11):818-32. PubMed ID: 2867933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on antiulcer drugs. IV. Synthesis and antiulcer activities of imidazo[1,2-a]pyridinylethylbenzothiazoles and -benzimidazoles.
    Katsura Y; Inoue Y; Nishino S; Tomoi M; Takasugi H
    Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1818-22. PubMed ID: 1356644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of pyridylthiazoles as antisecretory agents.
    Kosáry J; Kasztreiner E; Andrási F
    Pharmazie; 1989 Mar; 44(3):191-3. PubMed ID: 2748704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of gastric acid secretion by H2-receptor antagonists.
    Nielsen ST
    Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):151-60. PubMed ID: 2876686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [C-2 basically substituted thiazoles with H2-antagonistic action. 21. H2-antihistaminics].
    Trumm KA; Sattler HJ; Postius S; Szelenyi I; Schunack W
    Arzneimittelforschung; 1985; 35(3):573-7. PubMed ID: 2859863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
    Cavanagh RL; Usakewicz JJ; Buyniski JP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on antiulcer drugs. V. Synthesis and antiulcer activity of aralkylbenzazoles.
    Katsura Y; Inoue Y; Tomoi M; Takasugi H
    Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2062-74. PubMed ID: 1358470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on antiulcer drugs. 7. 2-Guanidino-4-pyridylthiazoles as histamine H2-receptor antagonists with potent gastroprotective effects against nonsteroidal antiinflammatory drug-induced injury.
    Katsura Y; Inoue Y; Tomishi T; Ishikawa H; Takasugi H
    J Med Chem; 1994 Jan; 37(1):57-66. PubMed ID: 7904648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro effects of CM 57755, a new gastric antisecretory agent acting on histamine H2 receptors.
    Lavezzo A; Manzoni L; Aureggi G; Nisato D; Bianchetti A; Carminati P
    Int J Tissue React; 1984; 6(2):155-65. PubMed ID: 6145676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on MK-208 (YM-11170) a new, slowly dissociable H2-receptor antagonist.
    Pendleton RG; Torchiana ML; Chung C; Cook P; Wiese S; Clineschmidt BV
    Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):4-16. PubMed ID: 6141772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on antiulcer drugs. VI. 4-Furyl-2-guanidinothiazoles and related compounds as potent histamine H2-receptor antagonists.
    Katsura Y; Inoue Y; Tomishi T; Itoh H; Ishikawa H; Takasugi H
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2432-41. PubMed ID: 1359931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
    Muramatsu M; Isobe Y; Arai I; Hirose-Kijima H; Usuki-Ito C; Nagai H; Aihara H; Otomo S
    Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,3,3-Trimethyl-N-(2-pyridyl)-2-oxabicyclo[2.2.2]octan-6-amine derivatives with hypotensive and other activities.
    Mariani E; Bruno O; Schenone P; De Santis D; Di Mauro G; Marmo E
    Farmaco Sci; 1986 Jun; 41(6):454-63. PubMed ID: 3743741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological comparison of ORF 17910, a potent, long-acting histamine H2-receptor antagonist, to cimetidine and ranitidine.
    Katz LB; Scott CK; Shriver DA
    J Pharmacol Exp Ther; 1986 Aug; 238(2):587-93. PubMed ID: 2874214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antisecretory profile of action of the H2-receptor antagonists, famotidine, loxtidine, ranitidine and L-643,441 on the rat isolated gastric mucosa.
    Reeves JJ; Stables R
    Agents Actions; 1987 Feb; 20(1-2):22-8. PubMed ID: 2883848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of the novel H2 antagonist famotidine: in vitro studies.
    Bertaccini G; Coruzzi G; Poli E; Adami M
    Agents Actions; 1986 Nov; 19(3-4):180-7. PubMed ID: 2881455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthesis and antiulcer activity of N-2-(2-hydroxy-2-phenyl)ethyl-N"-(methanesulfonyl)guanidine analogue of ranitidine. Development of a new antiulcer agent T-593].
    Shibata H; Kusayanagi Y; Arai H; Hashiba K; Yamamoto Y; Onoda M
    Yakugaku Zasshi; 1998 Mar; 118(3):88-104. PubMed ID: 9549432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisecretory and antiulcer activities of a potent new histamine H2-receptor antagonist with an intermediate duration of action.
    Borella L; Russell J; Rimele TJ; Grimes D; Failli A; Mir GN
    Arzneimittelforschung; 1988 Mar; 38(3):366-72. PubMed ID: 2898247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New derivatives of pyrrolo and pyrido[2,1-b] quinazoline as antiulcer agents.
    Doria G; Passarotti C; Magrini R; Sala R; Sberze P; Tibolla M; Arcari G; Ceserani R; Castello R
    Farmaco Sci; 1984 Nov; 39(11):968-78. PubMed ID: 6519266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.